PMID- 12898778
OWN - NLM
STAT- MEDLINE
DCOM- 20030822
LR  - 20161206
IS  - 0035-9351 (Print)
IS  - 0035-9351 (Linking)
VI  - 82
IP  - 6
DP  - 2003 Jun
TI  - [Patient survival analysis in surgery of bronchogenic carcinoma from 1986 to 
      1997].
PG  - 293-9
AB  - Surgery is the most effective treatment of lung cancer (LC) in early stage 
      disease (I-IIIa) of non small cell lung carcinoma (NSCLC). Even in resectable 
      patients there are differences in survival accordingly to some prognostic 
      factors. In 12 years period (1986-1997) there were 363 resected patients, in 350 
      of them lung cancer was confirmed. This group was analysed according to 
      morphologic types, stages, and sex of patients, co morbidity and the type 
      subsequent adjuvant therapy in relation to survival. Sensitivity and specificity 
      of staging methods were also evaluated as well as the impact of staging accuracy 
      to survival. Epidermoid cancer was found in 193 patients (55%), adenocarcinoma in 
      124 (36%), large cell-anaplastic type in 29 patients (8%) and small cell lung 
      cancer in 4 patients (1%). Early postoperative mortality is 4%. 5 year after 
      surgical resection survive 26% (90 patients). Other results are given in the 
      text. Surgery of LC remains optimal therapeutic method. Survival of patients 
      after lung resection doesn't change significantly in last years, even that we can 
      use much more better diagnostic methods now. The way for the future seems to be 
      the preoperative chemotherapy and the biologic target therapy. We need more 
      precious staging procedures and more effective adjuvant therapeutic schedules in 
      early as well as more advanced stages.
FAU - Plickova, K
AU  - Plickova K
AD  - Klinika TRN, FN, Plzen. plickova@fnplzen.cz
FAU - Spidlen, V
AU  - Spidlen V
FAU - Pesek, M
AU  - Pesek M
FAU - Mukensnabl, P
AU  - Mukensnabl P
LA  - cze
PT  - English Abstract
PT  - Journal Article
TT  - Analyza preziti pacientu operovanych pro bronchogenni karcinom v letech 
      1986-1997.
PL  - Czech Republic
TA  - Rozhl Chir
JT  - Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti
JID - 9815441
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Carcinoma, Bronchogenic/*mortality/*surgery
MH  - Female
MH  - Humans
MH  - Lung Neoplasms/*mortality/*surgery
MH  - Male
MH  - Middle Aged
MH  - Survival Rate
EDAT- 2003/08/06 05:00
MHDA- 2003/08/23 05:00
CRDT- 2003/08/06 05:00
PHST- 2003/08/06 05:00 [pubmed]
PHST- 2003/08/23 05:00 [medline]
PHST- 2003/08/06 05:00 [entrez]
PST - ppublish
SO  - Rozhl Chir. 2003 Jun;82(6):293-9.